Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XILLIX FDA APPROVED -- Ignore unavailable to you. Want to Upgrade?

To: hsg who wrote (476)	7/24/1999 5:32:00 PM
From: Mike G	Read Replies (2) \| Respond to of 572

I have been sitting on the sidelines of this one, never did own a share, only heard about the company from my brother, and that was when it was around $4.00. Was tempted when it hit $1.00 as I had heard an analyst predicting $3.40 in 2 years. Glad I didn't jump in. It seems to me to be a natural that XLX would team up with QLT phototheraputics, also a Vancouver Company that are into using light to destroy cancer cells. If XLX has any good technology at all, then they should survive with a strong partner. No partner, and ? Just my opinion. I'll still watch this one, and when it has some stability, might jump in. Mike G